Clinical Trials Sponsored by Bioven Europe
Total 4168 results
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)Czech Republic, Switzerland
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Croatia, Russian Federation, India, Spain, New Zealand, Canada, Belgium, Netherlands, Bulgaria, Serbia, Greece, Ukraine, Mexico, Georgia, Colombia, Germany, Poland, United Kingdom, Czech Republic, France, Chile, Romania, Eston... and more
-
BiogenCompletedHealthyNetherlands, United States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedAdvanced Solid TumorsUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom, Ireland
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Puerto Rico
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
BiogenCompleted
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
BiogenTerminatedRheumatoid ArthritisArgentina, Brazil, Hungary, Mexico, Poland, Romania, Russian Federation, United Kingdom
-
BiogenTerminatedRheumatoid ArthritisUnited States
-
BiogenCompletedMultiple SclerosisBelgium
-
BiogenCompletedHealthyUnited States, Italy, France
-
BiogenTerminatedChronic Lymphocytic LeukemiaFrance, United States, Belgium, Australia, Austria, Poland, Canada, United Kingdom
-
BiogenCompletedChronic Lymphocytic LeukemiaUnited States
-
BiogenCompleted
-
BiogenCompletedSciatica | Radiculopathy | Painful Lumbar RadiculopathyUnited States
-
BiogenCompletedMultiple SclerosisGermany
-
BiogenCompleted
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Germany, Russian Federation, India, New Zealand, Spain, Belgium, Colombia, Canada, Bulgaria, Serbia, Greece, Peru, Ukraine, Poland, United Kingdom, Croatia, France, Romania, Chile, Czech Republic, Mexico, Estonia, Georgia, Latv... and more
-
BiogenTerminated
-
BiogenCompletedMultiple SclerosisSweden, France, United Kingdom, Germany, Denmark, Netherlands, Slovakia, Switzerland, Norway, Portugal
-
BiogenCompletedMultiple Sclerosis | Pregnancy | Prenatal Exposure Delayed EffectsUnited States
-
BiogenTerminatedMultiple SclerosisUnited States
-
BiogenCompleted
-
BiogenCompletedHepatocellular CarcinomaUnited States, Singapore, Taiwan, United Kingdom
-
BiogenCompletedRheumatoid ArthritisCzech Republic, Poland, Slovakia, India, Australia, Canada
-
BiogenCompletedChronic Lymphocytic LeukemiaUnited States
-
BiogenCompletedNon-Small Cell Lung CancerUnited States
-
BiogenTerminatedMultiple SclerosisUnited States
-
BiogenCompleted
-
BiogenCompletedHealthy VolunteersUnited States
-
BiogenCompletedChronic Inflammatory Demyelinating PolyradiculoneuropathyUnited States, Australia, Canada, United Kingdom
-
BiogenCompletedNon-Hodgkin's LymphomaSweden, Czech Republic, France, Russian Federation, Turkey, United Kingdom, Germany, Lithuania, Romania, United States, Austria
-
BiogenCompletedLymphoma | TumorsUnited Kingdom, United States
-
BiogenCompletedColorectal Carcinoma | MetastasesUnited States
-
BiogenTerminatedRelapsing Remitting Multiple SclerosisAustralia
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
BiogenCompletedRheumatoid ArthritisPoland, United States
-
BiogenCompletedMultiple SclerosisUnited States
-
BiogenRecruiting
-
BiogenRecruitingRelapsing Forms of Multiple SclerosisSpain, United States, Italy, Switzerland, Germany, Bulgaria, Czechia, Poland, Puerto Rico, Romania